Appili Therapeutics Inc (APLI) — Capital Reinvestment Ratio

Latest as of March 2025: 0.00x

Appili Therapeutics Inc (APLI) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow (CA$1.03 Million) in capital expenditures (CA$2.36K). See net asset quality index of Appili Therapeutics Inc to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

CA$1.03 Million

CAD

Capital Expenditures

CA$2.36K

CAD

Data as of

Mar 2025

Most recent filing

Appili Therapeutics Inc Capital Reinvestment Ratio (2025–2025)

This chart tracks Appili Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check Appili Therapeutics Inc (APLI) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Appili Therapeutics Inc (2025–2025)

Year-by-year Capital Reinvestment Ratio for Appili Therapeutics Inc from 2025 to 2025. For live market cap and broader valuation context, see how much is Appili Therapeutics Inc worth.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change
2025	0.00x	CA$868.82K	CA$2.36K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow